WHO has issued an alert on three substandard Indian cough syrups—Coldrif, Respifresh TR, and ReLife—linked to child deaths due to Diethylene Glycol contamination. Healthcare providers are urged to report adverse effects. Production has been halted, recalls initiated, and global regulatory bodies are advised to increase surveillance.